Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 8/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24201339 | 0.86 | EPHX2 (0.45) | ALDH1A1EPHX2KMT2AMEN1 | |
| SCHEMBL24201248 | 0.86 | EPHX2 (0.45) | ALDH1A1EPHX2KMT2AMEN1 | |
| SCHEMBL24201335 | 0.83 | ALDH1A1 (0.59) | ALDH1A1EPHX2HTTKMT2AMEN1 | |
| SCHEMBL24201256 | 0.81 | EPHX2 (0.41) | ALDH1A1EPHX2HTTKMT2AMEN1 | |
| SCHEMBL24201351 | 0.79 | EPHX2 (0.43) | ALDH1A1EPHX2CYP3A4CYP2C19 | |
| SCHEMBL24201251 | 0.79 | EPHX2 (0.43) | ALDH1A1EPHX2CYP3A4CYP2C19 | |
| SCHEMBL22185943 | 0.75 | ALDH1A1 (0.73) | ALDH1A1EPHX2KMT2AMEN1CYP3A4 | |
| SCHEMBL24201216 | 0.72 | OPRK1 (0.32) | — | |
| SCHEMBL5675925 | 0.71 | ALDH1A1 (0.53) | ALDH1A1EPHX2HTTKMT2AMEN1 | |
| SCHEMBL24201205 | 0.67 | ALDH1A1 (0.51) | ALDH1A1EPHX2KMT2AMEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3618833-B1 | TRIPARTITE ANDROGEN RECEPTOR ELIMINATORS, METHODS AND USES THEREOF | SPG THERAPEUTICS INC (US) | 2022-01-19 | — | — | EP | disclosed |